Cheruvu Pavan — SEC insider filings
SEC reporting owner CIK 1731741. 6 insider filings on record with FilingPulse; latest filed 2026-10-13.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2021-03-19 to 2026-10-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 100,000 shares, $248,180 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: purchase of 100,000 shares @ $2.48 ($248,180) in Sio Gene Therapies Inc., filed 2021-03-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Sio Gene Therapies Inc. (SIOX) | Chief Executive Officer, Director | 4 | 1 leg · 100,000 sh · $248,180 | — | 6 |
| Retension Pharmaceuticals, Inc. (RTSN) | Director | 2 | — | — | 1 |
Insider filings — Cheruvu Pavan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-13 | 3 | Retension Pharmaceuticals, Inc. (RTSN) | Holdings only — no transactions reported | EDGAR |
| 2026-10-13 | 4 | Retension Pharmaceuticals, Inc. (RTSN) | Grant/award (A): 5,636 (derivative) @ $0 | EDGAR |
| 2021-12-09 | 4 | Sio Gene Therapies Inc. (SIOX) | Grant/award (A): 37,567 @ $0 · Tax withholding (F): 14,884 @ $1.42 · Disposition to issuer (D): 37,567 (derivative) @ $0 | EDGAR |
| 2021-04-19 | 4 | Sio Gene Therapies Inc. (SIOX) | Grant/award (A): 682,100 (derivative) @ $0 | EDGAR |
| 2021-03-24 | 4 | Sio Gene Therapies Inc. (SIOX) | Purchase (P): 100,000 @ $2.48 | EDGAR |
| 2021-03-19 | 4 | Sio Gene Therapies Inc. (SIOX) | Grant/award (A): 22,590 @ $0 · Disposition to issuer (D): 22,590 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-03-15 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1731741 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs